Literature DB >> 21248157

Mucosal immunologic responses in cholera patients in Bangladesh.

Taher Uddin1, Jason B Harris, Taufiqur Rahman Bhuiyan, Tahmina Shirin, Muhammad Ikhtear Uddin, Ashraful Islam Khan, Fahima Chowdhury, Regina C LaRocque, Nur Haque Alam, Edward T Ryan, Stephen B Calderwood, Firdausi Qadri.   

Abstract

Vibrio cholerae O1 causes dehydrating diarrhea with a high mortality rate if untreated. The infection also elicits long-term protective immunity. Since V. cholerae is noninvasive, mucosal immunity is likely important for protection. In this study, we compared humoral immune responses in the duodenal mucosa and blood of cholera patients at different time points after the onset of disease and compared them with those of healthy controls (HCs). Immune responses to lipopolysaccharide (LPS) and the recombinant cholera toxin B subunit (rCTB) were assessed by enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immunospot (ELISPOT) assay. Significant increases in V. cholerae LPS-specific IgA and IgG antibody levels were seen in duodenal extracts on day 30, but the levels decreased to baseline by day 180; plasma V. cholerae LPS-specific IgA levels remained elevated longer. Levels of mucosal CTB antibodies also peaked on day 30, but the increase reached statistical significance only for IgG. A significant correlation was found between the CTB antibody-secreting cell (ASC) response in the circulatory system on day 7 and subsequent CTB-specific IgA levels in duodenal extracts on day 30 and the numbers of CTB-specific IgA ASCs in duodenal tissues on day 180. The proportion (0.07%) of mucosal V. cholerae LPS IgA ASCs peaked on day 30 and remained elevated through day 180 compared to that of HCs (P = 0.03). These results suggest that protective immunity against V. cholerae is not likely mediated by the constitutive secretion of antibodies at the mucosal surface; our results are consistent with those of other studies that suggest instead that anamnestic immune responses of mucosal lymphocytes may play a major role in protection against cholera.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248157      PMCID: PMC3067383          DOI: 10.1128/CVI.00481-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  24 in total

1.  Pathogen adaptation to seasonal forcing and climate change.

Authors:  Katia Koelle; Mercedes Pascual; Md Yunus
Journal:  Proc Biol Sci       Date:  2005-05-07       Impact factor: 5.349

2.  Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients.

Authors:  Anna Lundgren; Erika Strömberg; Asa Sjöling; Catharina Lindholm; Karin Enarsson; Anders Edebo; Erik Johnsson; Elisabeth Suri-Payer; Pia Larsson; Anna Rudin; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  The regulation of IgA class switching.

Authors:  Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

4.  Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation.

Authors:  Taufiqur Rahman Bhuiyan; Samuel B Lundin; Ashraful Islam Khan; Anna Lundgren; Jason B Harris; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

5.  Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.

Authors:  Sohel Shamsuzzaman; Tanvir Ahmed; Kaiissar Mannoor; Yasmin Ara Begum; Pradip Kumar Bardhan; R Bradley Sack; David A Sack; Ann-Mari Svennerholm; Jan Holmgren; Firdausi Qadri
Journal:  Vaccine       Date:  2009-01-13       Impact factor: 3.641

6.  Memory T-cell responses to Vibrio cholerae O1 infection.

Authors:  Ana A Weil; Mohammad Arifuzzaman; Taufiqur R Bhuiyan; Regina C LaRocque; Aaron M Harris; Emily A Kendall; Azim Hossain; Abdullah A Tarique; Alaullah Sheikh; Fahima Chowdhury; Ashraful I Khan; Farhan Murshed; Kenneth C Parker; Kalyan K Banerjee; Edward T Ryan; Jason B Harris; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

7.  Comparison of mucosal B- and T-cell responses in Helicobacter pylori-infected subjects in a developing and a developed country.

Authors:  Taufiqur Rahman Bhuiyan; Firdausi Qadri; Prodip Kumar Bardhan; Mian Mashhud Ahmad; Bert Kindlund; Ann-Mari Svennerholm; Anna Lundgren
Journal:  FEMS Immunol Med Microbiol       Date:  2008-07-09

8.  Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh.

Authors:  Aaron M Harris; M Saruar Bhuiyan; Fahima Chowdhury; Ashraful I Khan; Azim Hossain; Emily A Kendall; Atiqur Rahman; Regina C LaRocque; Jens Wrammert; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood; Jason B Harris
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

Review 9.  Cholera transmission: the host, pathogen and bacteriophage dynamic.

Authors:  Eric J Nelson; Jason B Harris; J Glenn Morris; Stephen B Calderwood; Andrew Camilli
Journal:  Nat Rev Microbiol       Date:  2009-10       Impact factor: 60.633

10.  Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh.

Authors:  Jason B Harris; Regina C LaRocque; Fahima Chowdhury; Ashraful I Khan; Tanya Logvinenko; Abu S G Faruque; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  PLoS Negl Trop Dis       Date:  2008-04-09
View more
  28 in total

1.  Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Authors:  Kara J Levinson; Magdia De Jesus; Nicholas J Mantis
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.

Authors:  Kara J Levinson; Danielle E Baranova; Nicholas J Mantis
Journal:  Vaccine       Date:  2016-10-20       Impact factor: 3.641

3.  Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Authors:  Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

4.  Enumeration of Gut-Homing β7-Positive, Pathogen-Specific Antibody-Secreting Cells in Whole Blood from Enterotoxigenic Escherichia coli- and Vibrio cholerae-Infected Patients, Determined Using an Enzyme-Linked Immunosorbent Spot Assay Technique.

Authors:  Taufiqur Rahman Bhuiyan; Mohammad Rubel Hoq; Naoshin Sharmin Nishat; Deena Al Mahbuba; Rasheduzzaman Rashu; Kamrul Islam; Lazina Hossain; Ayan Dey; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Ann-Mari Svennerholm; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2015-10-28

5.  Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.

Authors:  Taher Uddin; Amena Aktar; Peng Xu; Russell A Johnson; M Arifur Rahman; Daniel T Leung; Sadia Afrin; Aklima Akter; Mohammad Murshid Alam; Atiqur Rahman; Fahima Chowdhury; Ashraful I Khan; Taufiqur Rahman Bhuiyan; Meagan K Bufano; Rasheduzzaman Rashu; Yanan Yu; Ying Wu-Freeman; Jason B Harris; Regina C LaRocque; Richelle C Charles; Pavol Kováč; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Am J Trop Med Hyg       Date:  2014-03-31       Impact factor: 2.345

6.  Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.

Authors:  Russell A Johnson; Taher Uddin; Amena Aktar; M Mohasin; Mohammad Murshid Alam; Fahima Chowdhury; Jason B Harris; Regina C LaRocque; Meagan Kelly Bufano; Yanan Yu; Ying Wu-Freeman; Daniel T Leung; David Sarracino; Bryan Krastins; Richelle C Charles; Peng Xu; Pavol Kovác; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

7.  LPLUNC1 modulates innate immune responses to Vibrio cholerae.

Authors:  Ok S Shin; Taher Uddin; Robert Citorik; Jennifer P Wang; Patricia Della Pelle; Richard L Kradin; Colin D Bingle; Lynne Bingle; Andrew Camilli; Taufiqur R Bhuiyan; Tahmina Shirin; Edward T Ryan; Stephen B Calderwood; Robert W Finberg; Firdausi Qadri; Regina C Larocque; Jason B Harris
Journal:  J Infect Dis       Date:  2011-09-07       Impact factor: 5.226

8.  Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.

Authors:  Sweta M Patel; Mohammad Arif Rahman; M Mohasin; M Asrafuzzaman Riyadh; Daniel T Leung; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful I Khan; Ana A Weil; Amena Aktar; Mohammad Nazim; Regina C LaRocque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Clin Vaccine Immunol       Date:  2012-04-18

Review 9.  Immune responses to cholera in children.

Authors:  Daniel T Leung; Fahima Chowdhury; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Expert Rev Anti Infect Ther       Date:  2012-04       Impact factor: 5.091

10.  Assessing antigen specific HLA-DR+ antibody secreting cell (DR+ASC) responses in whole blood in enteric infections using an ELISPOT technique.

Authors:  Taufiqur Rahman Bhuiyan; Mohammad Rubel Hoq; Naoshin Sharmin Nishat; Deena Al Mahbuba; Rasheduzzaman Rashu; Kamrul Islam; Lazina Hossain; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Ann-Mari Svennerholm; Firdausi Qadri
Journal:  Microbes Infect       Date:  2017-11-08       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.